Psychopharmacological treatment in emergency medicine;Psychopharmakotherapie in der Notfallmedizin

Notfall und Rettungsmedizin

Volumn 9, Issue 4, 2006, Pages 393-402

  Pajonk, F G ^a   Stoewer, S ^a   Kinn, M ^a   Fleiter, B ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b Gemeinschaftspraxis für Laboratoriumsmedizin   (Germany)

Author keywords

Antipsychotics; Benzodiazepines; Crisis intervention; Psychiatric emergencies; Rapid tranquilisation

Indexed keywords

EID: 33745147889     PISSN: 14346222     EISSN: 14360578     Source Type: Journal    
DOI: 10.1007/s10049-006-0831-1     Document Type: Article

References (80)

1. Aleman A, Kahn RS (2001) Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. Eur Neuropsychopharmacol 11: 289-293
2. Alexander J, Tharyan P, Adams C, John T, Mol C, Philip J (2004) Rapid tranquilisation of violent or agitated patients in a psychiatric emergency setting. Br J Psychiatry 185: 63-69
3. Atakan Z, Davies T (1997) ABC of mental health. Mental health emergencies. BMJ 314: 1740-1742
4. Barbee JG, Mancuso DM, Freed CR, Todorov AA (1992) Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia. Am J Psychiatry 149: 506-510
5. Barr J, Zomorodi K, Bertaccini EJ, Shafer SL, Geller E (2001) A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 95: 286-298
6. Battaglia J, Moss S, Rush J et al. (1997) Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 15: 335-340
7. Baust W (1983) Klinische Aspekte zur Beurteilung von Schlafmitteln. Int Welt 2: 51-56
8. Belgamwar RB, Fenton M (2005) Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses. Cochrane Database Syst Rev CD003729
9. Benkert O, Hippius H (1996) Psychiatrische Pharmakotherapie, 6. Aufl. Springer, Berlin Heidelberg New York Tokio
10. Benkert O, Hippius H (2005) Kompendium der psychiatrischen Pharmakotherapie, 5. Aufl. Springer, Berlin Heidelberg New York Tokio
11. Berkowitz JM (1978) A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology. J Clin Psychiatry 39: 46-52
12. Berzewski H (2005) Panik, generalisierte Angststörung und Phobien. In: Madler C, Jauch KW, Werdan K, Siegrist J, Pajonk FG (Hrsg) Das NAW-Buch. Akutmedizin der ersten 24 Stunden, 3. Aufl. Elsevier Urban & Fischer, München, S 784-793
13. Bieniek SA, Ownby RL, Penalver A, Dominguez RA (1998) A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation. Pharmacotherapy 18: 57-62
14. Braun J, Preuss R (1998) Klinikleitfaden Intensivmedizin, 4. Aufl. Urban & Fischer, München
15. Breier A, Meehan K, Birkett M et al. (2002) A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 59: 441-448
16. Brook S (2003) Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia. J Clin Psychiatry 64 (Suppl 19): 13-18
17. Brook S, Lucey JV, Gunn KP (2000) Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group. J Clin Psychiatry 61: 933-941
18. Cavanaugh SV (1986) Psychiatric emergencies. Med Clin North Am 70: 1185-1202
19. Cernaianu AC, DelRossi AJ, Flum DR et al. (1996) Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost. Crit Care Med 24: 222-228
20. Citrome L (2002) Atypical antipsychotics for acute agitation. New intramuscular options offer advantages. Postgrad Med 112: 85-88, 94-96
21. Clinton JE, Sterner S, Stelachers Z, Ruiz E (1987) Haloperidol for sedation of disruptive emergency patients. Ann Emerg Med 16: 319-322
22. Currier GW (2000) Atypical antipsychotic medications in the psychiatric emergency service. J Clin Psychiatry 61 (Suppl 14): 21-26
23. Currier GW, Allen MH, Bunney EB et al. (2004) Intramuscular antipsychotics: clinical experience review. J Emerg Med 27: S3-4
24. Currier GW, Simpson GM (2001) Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J Clin Psychiatry 62: 153-157
25. D'Amelio R, Archonti C, Falkai P, Pajonk FG (2006) Psychologische Konzepte und Möglichkeiten der Krisenintervention in der Notfallmedizin. Notfall Rettungsmed 9: 194-204
26. Daniel DG, Potkin SG, Reeves KR, Swift RH, Harrigan EP (2001) Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology 155: 128-134
27. Derlet RW, Albertson TE, Rice P (1989) The effect of haloperidol in cocaine and amphetamine intoxications. J Emerg Med 7: 633-637
28. Dubin WR, Feld JA (1989) Rapid tranquilization of the violent patient. Am J Emerg Med 7: 313-320
29. Dubin WR, Weiss KJ, Dorn JM (1986) Pharmacotherapy of psychiatric emergencies. J Clin Psychopharmacol 6: 210-222
30. Dudley DL, Rowlett DB, Loebel PJ (1979) Emergency use of intravenous haloperidol. Gen Hosp Psychiatry 1: 240-246
31. Ellison JM (1985) Emergency treatment of acute psychosis, agitation, and anxiety. Hospital Comm Psychiatr 36: 351-352
32. Evans L (1977) The role of drug therapy in emergency psychiatry. Aust Fam Physician (Suppl 1): 21-24
33. Extein I (1980) Psychopharmacology in psychiatric emergencies. Int J Psychiatry Med 10: 189-204
34. Finkel S (1978) Antianxiety effects of lorazepam in patients with cardiovascular symptomatology. J Clin Psychiatry 39: 35-40
35. Foster S, Kessel J, Berman ME, Simpson GM (1997) Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting. Int Clin Psychopharmacol 12: 175-179
36. Fragen RJ (1997) Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. Clin Ther 19: 405-419
37. Gamble JA, Dundee JW, Assaf RA (1975) Plasma diazepam levels after single dose oral and intramuscular administration. Anaesthesia 30: 164-169
38. Goldney RD, Spence ND, Bowes JA (1986) The safe use of high dose neuroleptics in a psychiatric intensive care unit. Aust N Z J Psychiatry 20: 370-375
39. Golombek U, Diefenbacher A (2005) Persönlichkeitsstörungen - die schwierigen Patienten. In: Madler C, Jauch KW, Werdan K, Siegrist J, Pajonk FG (Hrsg) Das NAW Buch. Akutmedizin der ersten 24 Stunden, 3. Aufl. Elsevier Urban & Fischer, München, S 774-783
40. Greenblatt DJ, Shader RI, Franke K et al. (1979) Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci 68: 57-63
41. Gunasekara NS, Spencer CM, Keating GM (2002) Spotlight on ziprasidone in schizophrenia and schizoaffective disorder. CNS Drugs 16: 645-652
42. Hovens JE, Dries PJ, Melman CT, Wapenaar RJ, Loonen AJ (2005) Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study. J Psychopharmacol 19: 51-57
43. Jones B, Taylor CC, Meehan K (2001) The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptoms. J Clin Psychiatry 62 (Suppl 2): 22-24
44. Jusic N, Lader M (1994) Post-mortem antipsychotic drug concentrations and unexplained deaths. Br J Psychiatry 165: 787-791
45. Ketai R (1975) Psychotropic drugs in the management of psychiatric emergencies. Postgraduate Medicine 58: 87-93
46. Kinon BJ, Ahl J, Rotelli MD, McMullen E (2004) Efficacy of accelerated dose titration of olanzapine with adjunctive lorazepam to treat acute agitation in schizophrenia. Am J Emerg Med 22: 181-186
47. König F, Petersdorff T, von Hippel C, Kaschka WP (1999) Zur Erstversorgung psychiatrischer Notfallpatienten. Anästhesist 48: 542-548
48. Kudo S, Ishizaki T (1999) Pharmacokinetics of haloperidol. An update. Clin Pharmacokinet 37: 435-456
49. Lesem MD, Zajecka JM, Swift RH, Reeves KR, Harrigan EP (2001) Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry 62: 12-18
50. McAllister-Williams RH, Ferrier IN (2002) Rapid tranquilisation: time for a reappraisal of options for parenteral therapy. Br J Psychiatry 180: 485-489
51. Meehan K, Zhang F, David S et al. (2001) A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 21: 389-397
52. Menninger WW (1993) Management of the aggressive and dangerous patient. Bull Menninger Clin 57: 208-217
53. Meusert W (1971) Prüfung von Lorazepam in der nervenärztlichen Praxis. Arzneimittelforschung 21: 1087-1090
54. Moffet AU, Scott DF (1984) Stress and epilepsy. The value of a benzodiazepine - Lorazepam. J Neurol Neurosurg Psychiatry 47: 165-167
55. Möller HJ, Kissling W, Lang C, Doerr P, Pirke KM, von Zerssen D (1982) Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration. Am J Psychiatry 139: 1571-1575
56. Mutschler E (2001) Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie, 8. Aufl. Wiss. Verlagsgesellschaft, Stuttgart
57. Pajonk FG, Bartels HH, Biberthaler P, Bregenzer T, Moecke H (2001) Der psychiatrische Notfall im Rettungsdienst - Häufigkeit, Versorgung und Beurteilung durch Notärzte und Rettungsdienstpersonal. Nervenarzt 72: 685-692
58. Pajonk FG, Biberthaler P, Cordes O, Moecke H (1998) Psychiatrische Notfälle aus der Sicht von Notärzten. Anästhesist 47: 588-594
59. Pajonk FG, Fleiter B (2003) Psychopharmakotherapie im Notarztdienst. Anästhesist 52: 577-585
60. Pajonk FG, Moecke Hp (2005) Psychiatrische Notfälle in der Notfallmedizin - Definition, Häufigkeit, Epidemiologie. In: Madler C, Jauch KW, Werdan K, Siegrist J, Pajonk FG (Hrsg) Das NAW-Buch. Akutmedizin der ersten 24 Stunden, 3. Aufl. Elsevier Urban & Fischer, München, S 751-756
61. Pajonk FG, Schreiner A, Peters S, Rettig K, Degner D, Rüther E (2005) Risperidone. An open label, observational study of the efficacy, tolerability, and prescribing behavior in acutely exacerbated patients with schizophrenia. J Clin Psychopharmacol 25: 293-300
62. Pajonk FG, Volz HP (2003) Akuttherapie schizophrener Patienten. Thieme, Stuttgart
63. Preval H, Klotz SG, Southard R, Francis A (2005) Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study. Gen Hosp Psychiatry 27: 140-144
64. Reilly JG, Ayis SA, Ferrier IN, Jones SJ, Thomas SHL (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355: 1048-1052
65. Resnick M, Burton BT (1984) Droperidol vs. haloperidol in the initial management of acutely agitated patients. J Clin Psychiatry 45: 298-289
66. Ritter RM, Davidson DE (1971) Haloperidol for acute psychiatric emergencies: a double blind comparison with perphenazine in acute alcoholic psychosis. South Med J 64: 249-250
67. Salzman C, Solomon D, Miyawaki E, Glassman R, Rood L, Flowers E, Thayer S (1991) Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior. J Clin Psychiatry 52: 177-180
68. Seeler W, Wittgens R (1989) Psychiatrische Akutbehandlung. Ein klinischer Erfahrungsbericht mit Lorazepam pro injectione. Neurol Psychiatrie 3: 309-310
69. Shale JH, Shale CM, Mastin WD (2003) A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients. J Clin Psychiatry 64: 500-505
70. Shale JH, Shale CM, Mastin WD (2004) Safety of droperidol in behavioural emergencies. Expert Opin Drug Saf 3: 369-378
71. Silverstein S, Frommer DA, Marx JA, Rosen P (1986) Parenteral haloperidol in combative patients: a prospective study. Ann Emerg Med 15: 636
72. Sim M, Bindman E, Morrison I, Sandilands D (1975) Psychosomatic conditions in general practice: a double-blind controlled therapeutical trial of lorazepam vs. medazepam. Br J Clin Pract 29: 304-306
73. Thomas H, Schwartz E, Petrilli R (1992) Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med 21: 407-413
74. TREC Collaborative Group (2003) Rapid tranquilisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine. BMJ 327: 708-713
75. Trimble MR (1983) Benzodiazepines divided. A multidisciplinary review. Wiley, Chichester
76. Tulloch KJ, Zed PJ (2004) Intramuscular olanzapine in the management of acute agitation. Ann Pharmacother 38: 2128-2135
77. Walker JE, Homan RW, Crawford IL (1984) Lorazepam: a controlled trial in patients with intractable partial complex seizures. Epilepsia 25: 464-466
78. Weiss JMA (1973) Psychiatric emergencies. Drug Ther 3: 70-72
79. Wright P, Birkett M, David SR et al. (2001) Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. Am J Psychiatry 158: 1149-1151
80. Young CC, Prielipp RC (2001) Benzodiazepines in the intensive care unit. Crit Care Clin 17: 843-862